Tsarin hoto na bidiyo mai hoto ne kamar yadda, a zahiri, ƙuntatawa ko rage aikin da yin amfani da cutar. Yayin da ake magana akan maganin cutar HIV , an yi la'akari da tsarin da zai ci gaba da nasara idan ya rage girman nauyin hoto na jikin mutum zuwa matakan da ba a gane ba. Kalmar "nauyin hoto" yana nufin yawan adadin kwayar cutar ta HIV ta mL jini. A wasu kalmomi, yawancin kwayar cuta ne a cikin jini.
Ciyayyin hoto da kuma kwayar cutar HIV
Gaba ɗaya, mutanen da ke dauke da kwayar cutar HIV suna buƙatar amfani da farfado da maganin rigakafi (cART - wanda aka fi sani da babbar magungunan rigakafi ko HAART) don cimma burin maganin hoto. An bayyana wannan inda inda matakin yaduwar cutar a cikin jini ya kasance maras kyau ko maras tabbas. Hadin maganin rigakafi ya zama dole saboda HIV zai iya canzawa yayin da ake amfani da kwayar magani guda daya (wanda ake kira "monotherapy"). Zai fi wuya ga HIV ya zama magungunan miyagun ƙwayoyi a gaban wata magungunan miyagun kwayoyi. Gaskiya ne ko da idan waɗannan kwayoyi suna cikin kwayar kwayar guda daya .
Wasu lokuta, wani tsari na PC ɗin ba zai iya taimakawa wajen maganin kwayar cutar kwayar cutar HIV-tabbatacciyar haƙuri ba. A irin waɗannan lokuta, za a gwada sabon haɗuwa da kwayoyi har sai an sami cikakken maye gurbin hoto. Duk da haka, sakamakon gwajin da aka samu yana nuna cewa kwayoyin cutar HIV a cikin jini basu da mahimmanci kamar yadda aka gaya muku an warkar da ku daga cutar.
Ko da ko babu kwayar cuta a cikin jini, kwayoyin kamuwa da kwayar cutar kwayar cutar HIV za su iya kasancewa cikin jiki . Saboda haka, akwai yiwuwar kwayar cutar zata fara farawa (kwafin kansa) kuma idan an dakatar da farfadowa da maganin antiretroviral. Bugu da ƙari, samun cikewar kyamarar bidiyo mai mahimmanci yana nufin cewa akwai ƙananan ƙwayoyin cutar don gwaje-gwaje na yanzu.
A matsayin haka, "wanda ba a iya ganewa ba" shi ne manufa mai motsi. Shekaru ashirin da suka wuce, gwaje-gwajen ba su da kyau. Sabili da haka, abin da ake kira nauyin hoto na kwayoyin cutar ba shi da mahimmanci fiye da yadda suke a yau.
Wannan ya ce, akwai wadata mai yawa ga rike da kayan aikin kyamarar cutar. Mutanen da gwajin gwajin su nuna nauyin kyamaran bidiyo ba su da lafiya fiye da wadanda suke da sakamakon da suke nuna matakan cutar a cikin jini. Bugu da ƙari, mutanen da suka sami cikewar kyamarar cututtuka ba su da ƙananan ƙwayar cutar HIV zuwa ga maƙwabtansu. Wannan shine ka'ida da ke tafiyar da maganin rigakafi ko TasP. TaSP shi ne lokacin da aka bai wa mutanen da ke fama da kwayar cutar ta farko magani don inganta ba kawai lafiyarsu ba amma lafiyar al'ummarsu.
Cikakken bidiyo mai hoto a cikin Janar
Magungunan cutar HIV shine ainihin mahallin da mafi yawan mutane zasu ji lokacin kallon hoto . Duk da haka, ba shine kawai mahallin da yakamata maye gurbin hoto bane ya dace. Halin jikin mutum na iya kawar da maganin cututtukan hoto da kuma tsintsa kayan aiki mai hoto ya dace a cikin tattaunawa akan yawan cututtuka masu kamala. Wannan ya haɗa da wasu lokuta da ƙwayoyin cuta masu ciwon hauka ne suka kamu da shi . Tsarin hoto na bidiyo mai mahimmanci shine ma'auni na kulawa da kyau ga waɗannan ƙwayoyin cuta.
Yana da muhimmanci mu gane cewa, kamar yadda aka bayyana a sama, likita ba kullum dole ne don cimma burbushin hoto ba. Ga wasu ƙwayoyin cuta, a wasu lokuta, tsarin na rigakafi na iya rage matakan zuwa ma'ana cewa ba a gano cutar ba a cikin jini. A wasu lokuta, tsarin rigakafi zai iya kawar da cutar gaba daya. Duk da haka, maye gurbin hoto ba a saba amfani dasu ba don bayyana tsarin kawar da cutar daga jiki. Yawancin lokaci ana amfani dashi wajen bayyana yanayin da aka sarrafa cutar, amma inda har yanzu yake a matakan ƙananan (ko ma wanda ba a iya gani ba). Wannan iko zai iya cimma ko ta hanyar tsarin rigakafi ko ta hanyar magani.
Misalai: Da dama kwayoyi da aka yi amfani da su a matsayin tsarin kula da cutar ta HIV zai iya zama tasiri wajen kawar da cutar rashin ciwon hepatitis B. Wadannan kwayoyi sunyi la'akari da dual-effective akan duka ƙwayoyin cuta. Kwayar cutar HIV da hepatitis sukan samuwa tare a marasa lafiya.
Sources:
Engell CA, Pham VP, Holzman RS, Aberg JA. Amfani da ilimin Virologic na Amfani da Tenofovir / Emtricitabine don Bi da cutar Harsha B a Cutar HIV-Coinfected Patients. ISRN Gastroenterol. 2011; 2011: 405390.